| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Scott Cheryl serves as a Director at EVH and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 11 sells. Those positions are worth an estimated $448K at current prices.
Historically, Scott Cheryl's trades have earned a middling insider score of 68/100 across 8 rated trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +12.8%.
The biggest single holding is PGNY (~$448K) as Director. The recent filings there lean toward selling, a net 15,596 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 19, 2017 | EVH Evolent Health, Inc. | Director | Sell | 5,477 | $23.51 | $128,764.27 | -46.2% |